Study details
Enrolling now
MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
Clinical Nutrition Research Center, Illinois Institute of Technology
NCT IDNCT06555952ClinicalTrials.gov data as of Apr 2026
Target enrollment
80
Study length
about 2.4 years
Ages
40–60
Locations
1 site in IL
About this study
Researchers are testing if taking MegaNatural BP, a Grape seed Extract (GSE) supplement, helps lower blood pressure and improve heart health. The trial will assess how well the supplement affects inflammation and blood vessel function in adults with hypertension or pre-diabetes.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take MegaNatural-BP SR 150Mg Tablet
- 2.Take Placebo Capsule
Routeoral
Primary goalDifference in change of diastolic blood pressure
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug routes
oral
Endpoints
Primary: Difference in change of diastolic blood pressure, Difference in change of systolic blood pressure
Secondary: Change in inflammatory marker C-reactive protein
Body systems
Cardiology / Heart